Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naoluotong is a Traditional Chinese Medicine (TCM) combination product primarily used to improve cerebral circulation and treat symptoms associated with cerebrovascular insufficiency. It is a hybrid formulation that integrates chemical components with herbal extracts. The standard composition includes **methylhesperidin** and **thiamine (Vitamin B1)** alongside extracts from **Salvia miltiorrhiza** (Dan Shen), **Ligusticum chuanxiong** (Chuanxiong), **Astragalus membranaceus** (Huangqi), and **Pueraria lobata** (Gegen). This combination is designed to promote blood circulation, resolve blood stasis, and support neurological health. It is commonly prescribed in China for the treatment of cerebral arteriosclerosis, sequelae of stroke (such as cerebral infarction), and related symptoms including headache, dizziness, and limb numbness. The product is manufactured by several companies, including Guangdong Xinbao Pharmaceutical, and is typically administered in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on naoluotong.